Diagnostic and Prognostic Biomarkers of Common Urological Cancers Based on Aberrant DNA Methylation

References

• Capitanio U , MontorsiF . Renal cancer . Lancet387 ( 10021 ), 894 – 906 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen W , ZhengR , BaadePDet al. Cancer statistics in China, 2015 . CA Cancer J. Clin.66 ( 2 ), 115 – 132 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD , JemalA . Cancer statistics, 2015 . CA Cancer J. Clin.65 ( 1 ), 5 – 29 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Clark PE , AgarwalN , BiagioliMCet al. Bladder cancer . J. Natl Compr. Canc. Netw.11 ( 4 ), 446 – 475 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Desantis CE , LinCC , MariottoABet al. Cancer treatment and survivorship statistics, 2014 . CA Cancer J. Clin.64 ( 4 ), 252 – 271 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Babjuk M , BöhleA , BurgerMet al. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016 . Eur. Urol.71 ( 3 ), 447 – 461 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Mottet N , BellmuntJ , BollaMet al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent . Eur. Urol.71 ( 4 ), 618 – 629 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA . Hallmarks of cancer: the next generation . Cell144 ( 5 ), 646 – 674 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N . Comprehensive molecular characterization of clear cell renal cell carcinoma . Nature499 ( 7456 ), 43 – 49 ( 2013 ).
   PubMedGoogle Scholar
• Cancer Genome Atlas Research N . Comprehensive molecular characterization of urothelial bladder carcinoma . Nature507 ( 7492 ), 315 – 322 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network . The molecular taxonomy of primary prostate cancer . Cell163 ( 4 ), 1011 – 1025 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Herman JG , BaylinSB . Gene silencing in cancer in association with promoter hypermethylation . N. Engl. J. Med.349 ( 21 ), 2042 – 2054 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Taby R , IssaJP . Cancer epigenetics . CA Cancer J. Clin.60 ( 6 ), 376 – 392 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hao X , LuoH , KrawczykMet al. DNA methylation markers for diagnosis and prognosis of common cancers . Proc. Natl Acad. Sci. USA114 ( 28 ), 7414 – 7419 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Vrba L , FutscherBW . A suite of DNA methylation markers that can detect most common human cancers . Epigenetics13 ( 1 ), 61 – 72 ( 2017 ).
   Web of Science ®Google Scholar
• Golovastova MO , KorolevDO , TsoyLVet al. Biomarkers of renal tumors: the current state and clinical perspectives . Curr. Urol. Rep.18 ( 1 ), 3 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Mbeutcha A , LuccaI , MathieuR , LotanY , ShariatSF . Current status of urinary biomarkers for detection and surveillance of bladder cancer . Urol. Clin. North Am.43 ( 1 ), 47 – 62 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tanase CP , CodriciE , PopescuIDet al. Prostate cancer proteomics: current trends and future perspectives for biomarker discovery . Oncotarget8 ( 11 ), 18497 – 18512 ( 2017 ).
   PubMedGoogle Scholar
• Costa VL , HenriqueR , DanielsenSAet al. TCF21 and PCDH17 methylation: an innovative panel of biomarkers for a simultaneous detection of urological cancers . Epigenetics6 ( 9 ), 1120 – 1130 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Henrique R , JeronimoC . Molecular detection of prostate cancer: a role for GSTP1 hypermethylation . Eur. Urol.46 ( 5 ), 660 – 669 ; discussion 669 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Monteiro-Reis S , LecaL , AlmeidaMet al. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation . Eur. J. Cancer50 ( 1 ), 226 – 233 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zuiverloon TC , BeukersW , Van Der KeurKAet al. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine . BJU Int.109 ( 6 ), 941 – 948 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hu CY , MohtatD , YuYet al. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival . Clin. Cancer Res.20 ( 16 ), 4349 – 4360 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kandimalla R , Van TilborgAA , KompierLCet al. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers . Eur. Urol.61 ( 6 ), 1245 – 1256 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mundbjerg K , ChopraS , AlemozaffarMet al. Identifying aggressive prostate cancer foci using a DNA methylation classifier . Genome Biol.18 ( 1 ), 3 ( 2017 ).
   PubMedGoogle Scholar
• Wei JH , HaddadA , WuKJet al. A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma . Nat. Commun.6 , 8699 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Deng J , ShoemakerR , XieBet al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming . Nat. Biotechnol.27 ( 4 ), 353 – 360 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Dahmcke CM , StevenKE , LarsenLKet al. A Prospective blinded evaluation of urine-DNA testing for detection of urothelial bladder carcinoma in patients with gross hematuria . Eur. Urol.70 ( 6 ), 916 – 919 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Renard I , JoniauS , Van CleynenbreugelBet al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples . Eur. Urol.58 ( 1 ), 96 – 104 ( 2010 ).
   PubMedGoogle Scholar